Becton Dickinson vs Medtronic: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: Becton Dickinson and Medtronic side by side

1. 1897Becton Dickinson

   Company Foundation

   Maxwell W. Becton and Fairleigh S. Dickinson partner in New York City to form Becton, Dickinson and Company, initially distributing fever thermometers and hypodermic syringes.

2. 1906Becton Dickinson

   Incorporation & Manufacturing

   Becton, Dickinson and Company is officially incorporated in New Jersey and establishes its first dedicated manufacturing and assembly operations.

3. 1924Becton Dickinson

   Luer-Lok Innovation

   BD introduces the groundbreaking Luer-Lok syringe tip, establishing an industry-standard secure connection for hypodermic needles and preventing accidental needle detachment.

4. 1949Becton Dickinson

   Vacutainer Blood Collection

   BD invents and launches the revolutionary Vacutainer evacuated blood collection tube system, transforming clinical diagnostics and laboratory blood draws worldwide.

5. 1960Becton Dickinson

   NYSE Public Listing

   BD common stock is listed on the New York Stock Exchange under ticker symbol BDX, providing broad public liquidity and capital for international expansion.

6. 1975Becton Dickinson

   Global Diagnostic Expansion

   BD scales its global footprint across Europe and Asia, establishing state-of-the-art manufacturing plants for disposable medical consumables and diagnostic reagents.

7. 1986Becton Dickinson

   Automated Flow Cytometry

   BD pioneers advanced fluorescence-activated cell sorting (FACS) and flow cytometry instrumentation, accelerating immunology and oncology research.

8. 1995Becton Dickinson

   Safety-Engineered Devices

   In response to needlestick injuries and bloodborne pathogen transmission risks, BD introduces an extensive portfolio of safety-engineered needles and retractable syringes.

9. 2015Becton Dickinson

   CareFusion Acquisition ($12.2B)

   BD completes the massive $12.2 billion acquisition of CareFusion, integrating Pyxis automated dispensing systems and Alaris infusion pump technologies.

10. 2017Becton Dickinson

    C.R. Bard Acquisition ($24B)

    BD acquires C.R. Bard for $24 billion, dramatically expanding its Interventional segment into vascular, urology, oncology, and surgical specialty products.

11. 2022Becton Dickinson

    Embecta Spin-Off

    BD successfully completes the tax-free spin-off of its diabetes care business into an independent publicly traded company named Embecta Corp.

12. 2024Becton Dickinson

    Edwards Critical Care Acquisition ($4.2B)

    BD completes the strategic $4.2 billion acquisition of Edwards Lifesciences Critical Care product group, boosting advanced hemodynamic monitoring capabilities.

13. 2024Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

14. 2025Becton Dickinson

    Smart Connected Ecosystems

    BD accelerates deployment of AI-enabled smart connected medication management systems, smart infusion pumps, and non-invasive PureWick urine management solutions.

15. 2025Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

16. 2025Medtronic

    Hugo Robotic Surgery Global Expansion

    Expands commercial installations of the Hugo robotic-assisted surgery system across European and Asia-Pacific surgical centers for urologic and gynecologic procedures.

17. 2026Becton Dickinson

    Global Supply Chain Resiliency

    BD achieves record consolidated revenue of $19.37 billion, reinforcing its essential hospital consumable monopoly across 190+ countries.

18. 2026Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

19. 2026Medtronic

    Micra AV2 Next-Gen Leadless Pacemaker Deployments

    Accelerates global adoption of next-generation leadless dual-chamber ventricular pacemakers featuring extended battery longevity and automated AV synchrony algorithms.

20. 2027Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

21. 2027Medtronic

    AI-Powered Smart Diabetes Ecosystem Rollout

    Integrates automated insulin delivery algorithms and continuous glucose sensor intelligence into the MiniMed 780G ecosystem, improving time-in-range for diabetic patients globally.

22. 2028Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

23. 2029Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

24. 2030Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

25. 2031Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

26. 2032Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

27. 2033Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

28. 2034Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

29. 2035Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

30. 2036Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

31. 2037Medtronic

    Medtronic Platform Intelligence & Global Scaling Initiative

    Expands modern cloud-native architecture, automated regulatory compliance features, and AI-driven predictive insights across enterprise customer workloads worldwide.

Questions about Becton Dickinson vs Medtronic